Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Collegium Pharma (COLL)

Collegium Pharma (COLL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 819,197
  • Shares Outstanding, K 35,204
  • Annual Sales, $ 310,020 K
  • Annual Income, $ 26,750 K
  • 60-Month Beta 1.04
  • Price/Sales 2.66
  • Price/Cash Flow 9.19
  • Price/Book 4.36
Trade COLL with:

Options Overview

Details
  • Implied Volatility 55.94%
  • Historical Volatility 37.83%
  • IV Percentile 14%
  • IV Rank 19.44%
  • IV High 133.14% on 07/13/20
  • IV Low 37.31% on 04/09/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 24
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 2,031
  • Open Int (30-Day) 545

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.30
  • Number of Estimates 3
  • High Estimate 0.35
  • Low Estimate 0.25
  • Prior Year 0.01
  • Growth Rate Est. (year over year) +2,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.31 +4.30%
on 04/08/21
25.97 -10.40%
on 03/18/21
-1.42 (-5.75%)
since 03/16/21
3-Month
21.16 +10.00%
on 03/04/21
26.91 -13.53%
on 02/10/21
-0.79 (-3.28%)
since 01/15/21
52-Week
15.66 +48.60%
on 07/31/20
26.91 -13.53%
on 02/10/21
+4.29 (+22.60%)
since 04/16/20

Most Recent Stories

More News
Collegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and Provide Corporate Update

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, May 6, 2021 at 4:30 p.m. Eastern Time. The Company will discuss...

COLL : 23.27 (-0.81%)
Collegium Pharmaceutical: 4Q Earnings Snapshot

STOUGHTON, Mass. (AP) _ Collegium Pharmaceutical Inc. (COLL) on Thursday reported fourth-quarter net income of $7 million, after reporting a loss in the same period a year earlier.

COLL : 23.27 (-0.81%)
Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million

- 2020 First Full-Year of Profitability, Driven by Xtampza ER Revenue Growth and the Nucynta Acquisition -

COLL : 23.27 (-0.81%)
Collegium Pharmaceutical, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Collegium Pharmaceutical, Inc. (NASDAQ:COLL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February...

COLL : 23.27 (-0.81%)
Collegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and Provide Corporate Update

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, February 25, 2021 at 4:30 p.m. Eastern Time. The Company will...

COLL : 23.27 (-0.81%)
Collegium Pharma Shares Up 25.6% Since SmarTrend's Buy Recommendation (COLL)

SmarTrend identified an Uptrend for Collegium Pharma (NASDAQ:COLL) on November 6th, 2020 at $20.71. In approximately 3 months, Collegium Pharma has returned 25.57% as of today's recent price of $26.00....

COLL : 23.27 (-0.81%)
Monolithic Power Systems Set to Join S&P 500; Iridium Communications to Join S&P MidCap 400; Collegium Pharmaceutical to Join S&P SmallCap 600

, /PRNewswire/ -- S&P MidCap 400 constituent Monolithic Power Systems Inc. (NASD: MPWR) will replace TechnipFMC plc (NYSE: FTI) in the S&P 500, S&P SmallCap 600 constituent Iridium Communications Inc....

MPWR : 378.62 (-0.77%)
FTI : 7.27 (-0.68%)
IRDM : 40.81 (-1.73%)
COLL : 23.27 (-0.81%)
SPGI : 378.07 (+0.80%)
Collegium Provides 2021 Financial Guidance

- Xtampza ER Revenues Expected in the Range of $155.0 million to $165.0 million -

COLL : 23.27 (-0.81%)
Pain Relief Therapeutics Market Share 2020 : Growth Opportunities with Covid-19 Impact Analysis, Business Structure with Top Key Players Size, Development Plans and Challenges Forecast to 2026

The rising prevalence of chronic diseases such as a variety of cancers, osteoarthritis, stomach ulcer, chronic arthritis and diabetes are major key factor which drives the Global Pain Relief Therapeutics...

ABT : 124.35 (+0.33%)
ACRX : 1.2000 (-6.25%)
ACOR : 4.19 (+6.62%)
AXSM : 53.44 (+1.60%)
BAYRY : 16.2200 (+2.21%)
BDRFF : 105.7500 (+2.50%)
BDSI : 3.42 (-1.44%)
BMY : 65.46 (+1.58%)
COLL : 23.27 (-0.81%)
DEPO : 7.30 (+1.67%)
DRRX : 1.7100 (-4.47%)
EGLT : 0.0315 (-63.37%)
LLY : 189.25 (+1.79%)
FLXN : 9.41 (-2.69%)
GLPG : 79.15 (-0.30%)
HRTX : 17.87 (+0.79%)
KMPH : 8.60 (-2.05%)
MRK : 77.47 (+1.06%)
MESO : 8.94 (-0.67%)
NKTR : 19.00 (-1.86%)
NVS : 88.02 (+0.94%)
ORXOY : 5.3195 (+3.09%)
PFE : 38.57 (+2.58%)
REGN : 502.60 (+1.61%)
SRNE : 7.49 (+0.67%)
VRX.TO : 30.80 (-3.33%)
Collegium Pharmaceutical (COLL) Tops Q3 Earnings and Revenue Estimates

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 39.13% and 1.61%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?...

COLL : 23.27 (-0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 24.52
2nd Resistance Point 24.10
1st Resistance Point 23.68
Last Price 23.27
1st Support Level 22.84
2nd Support Level 22.42
3rd Support Level 22.00

See More

52-Week High 26.91
Last Price 23.27
Fibonacci 61.8% 22.61
Fibonacci 50% 21.28
Fibonacci 38.2% 19.96
52-Week Low 15.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar